Refine by
Hplc Articles & Analysis
32 news found
Creative Proteomics, a global leader in proteomics and bioanalytical services, has launched its state-of-the-art N-terminal Edman Degradation service, offering researchers a precise and reliable solution for protein sequence analysis. This service leverages the classic Edman Degradation method, refined with modern technology, to deliver unparalleled accuracy in determining the N-terminal ...
Profacgen, a leading provider of custom biotechnology services, is pleased to announce significant updates to its Antimicrobial Peptides (AMPs) Services, enhancing its capabilities to support the growing demand for alternative therapies in the fight against drug-resistant pathogens. As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its services to assist ...
BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate from project design to commercial production. With its well-established conjugation platform, BOC Sciences supports pharmaceutical and biotechnology clients at the forefront of drug conjugation. Peptide-drug conjugates (PDCs) are mainly used in anti-cancer therapy, which integrates the ...
Bioinformatics-Analysis is a subdivision of CD Genomics, providing reliable next-generation and third-generation high-throughput sequencing data analysis, database construction, and other related data analysis services utilizing comprehensive technology. The Product Manager at CD Genomics is pleased to announce the launch of the LC-MS/MS Data Analysis service, enabling high-performance, regulated ...
STEMart, a U.S.-based provider of comprehensive services for all stages of medical device development, has recently introduced API Impurity Identification services for clients in the medical device, pharmaceutical product, and consumer product industries using a variety of techniques under standard guidance. Impurities are chemical species that differ from the chemical compositions of desired ...
BySTEMart
BOC Sciences' monthly report released in August showed that its peptide products had vastly facilitated the R&D of cardiovascular therapies. February is set as American Heart Month since heart disease is the number one cause of death for most groups, affecting all ages, genders, and races. More than 600,000 Americans die from heart disease every year. The striking fact drives a great deal ...
Peptide drug conjugate (PDC) is emerging as a novel type of conjugate drug, showing advantageous features over antibody-drug conjugates (ADCs). As a dedicated peptide manufacturer, Creative Peptides provides a one-stop solution for all peptide drug bioconjugation needs to help pharmaceutical clients bring more PDCs to the market. Structurally, PDC mainly contains three elements—cytotoxin, ...
"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public As an active participant in the biotech and pharmaceutical industry, BOC Sciences ...
As a service provider for custom pharmaceutical formulation projects, CD Formulation announces today that it is able to conduct API-excipient compatibility analysis service for clients across the globe with drug development demands. “The testing and analysis of the API-excipient compatibility is an extremely critical step in the drug preformualtion stage. We know that a drug substance is ...
BOC Sciences recently initiated an unprecedentedly comprehensive CDMO service platform to accelerate technology transfer of medicines from research to commercial scale. CDMO services are not new at BOC Sciences. Rather, as a reputed CDMO service provider, BOC Sciences has extensively contributed to the development and production of small molecules, oligonucleotides, peptides, various chemically ...
BOC Sciences recently initiated an unprecedentedly comprehensive CDMO service platform to accelerate technology transfer of medicines from research to commercial scale. CDMO services are not new at BOC Sciences. Rather, as a reputed CDMO service provider, BOC Sciences has extensively contributed to the development and production of small molecules, oligonucleotides, peptides, various chemically ...
Pronalyse, a division of Creative Proteomics, is an integrated CRO company with rich experience in providing drug development services. To ensure drug identity, strength, potency, purity, and safety, Creative Proteomics Pronalyse announced the launch of therapeutic enzyme characterization services. Enzymes play a major role in the pharmaceutical industry today due to their ability to ...
Alfa Chemistry, a supplier of high-quality analytical standards, reagents, and sample preparation products, announces to expand its offerings of chromatography standards by adding life sciences standards. After this step is fully implemented, researchers worldwide can easily find the most commonly seen life sciences standards they need from Alfa Chemistry. In life science research, methods like ...
Pronalyse is a new division of Creative Proteomics, which is an integrated CRO company with rich experience in providing drug development services. The product manager of the company is excited to launch the Gene Therapy Products Characterization service to help clients overcome the challenges of gene therapy analytical development, which include characterization, quality control, and the need to ...
Pronalyse, a new division of Creative Proteomics, is an integrated CRO company with rich experience in providing drug development services for over 10 years. Creative Proteomics Pronalyse recently announced the launch of antibody-drug conjugates (ADCs) characterization service to ensure the safety and effectiveness of ADCs drugs. In recent years, there has been a global upsurge in the research ...
Pronalyse is a new division of Creative Proteomics, which is an integrated CRO company with rich experience in providing drug development service for over 10 years. The company has recently announced Protein Drug Modification Analysis service to help researchers determine the modification type, modification site, and modification structure of protein drugs. Mature protein medicines have complete ...
Pronalyse is a new division of Creative Proteomics, which is an integrated CRO with rich experience in providing drug development services for over 10 years. To assist customers in understanding the changes in protein charge heterogeneity throughout manufacturing and purification, Creative Proteomics Pronalyse offers antibody drug charge variant analysis services using isoelectric focusing or ion ...
Creative Biostructure Drug Discovery, a sub-brand of Creative Biostructure, established to apply its expertise in structural biology and membrane proteins to drug discovery process, now offers natural product identification and production service for drug discovery from natural products. Natural products are the source of chemical diversity and are the ideal starting point for most small ...
Recognized as a CRO for pharmaceutical formulation, CD Formulation recently announces to have optimized its stability analysis service, providing solid-state stability analysis, solution-state stability analysis, APIs-excipients compatibility analysis for researchers devoted to drug formulation research. Current Good Manufacturing Practice for Finished Pharmaceuticals (CGMPs) has already ...
CD Formulation is a service provider for custom pharmaceutical formulation projects, providing diverse CRO services for pharmaceutical formulation development. Earlier this month, the company announced that a full range of drug analysis services are now available for clients across the globe who are engaged with new drug development. The analytical testing of pharmaceutical products involves ...